Investigational Antibody IgG1-iS18 Reduces Amyloid Load, Improves Memory in Mice

Investigational Antibody IgG1-iS18 Reduces Amyloid Load, Improves Memory in Mice
An investigational antibody effectively targeted toxic protein aggregation in the brain of a mouse model of Alzheimer’s disease, improving memory and cognitive functions in the animals. University of the Witwatersrand researchers are now planning Phase 1 of human clinical trials with 30 to 50 volunteers who have Alzheimer’s. If the results are positive, the team hopes to get regulatory approval on a

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

2 comments

Leave a Comment

Your email address will not be published. Required fields are marked *